This report provides a comprehensive analysis of the global sealed radioactive source market, projecting steady growth from 2025 through 2032. It examines key segments including medical and industrial applications, categorized by isotope type, radiation type, and IAEA safety levels. The study explores critical market drivers such as rising cancer incidence and infrastructure expansion, while addressing challenges like stringent regulatory frameworks and competition from radiation-free technologies. Detailed regional insights and competitive landscapes of leading global players are also provided.

Market Overview

The global Sealed Radioactive Source market is projected to grow from US$ 1076 million in 2025 to US$ 1472 million in 2032, representing a compound annual growth rate (CAGR) of 4.7% from 2026 to 2032.

Product Definition and Technical Specifications

Definition

A Sealed Radioactive Source is defined as radioactive material that is permanently sealed in a capsule or closely bonded in a solid form. The primary design objective is to prevent the leakage or dispersal of radioactive substances under normal conditions of use and during foreseeable accidents, while allowing ionizing radiation (such as gamma, X-rays, or neutrons) to pass through the capsule for its intended application.

Construction and Standards

• Encapsulation Materials: Typically composed of high-strength, corrosion-resistant materials including stainless steel, titanium, or platinum.
• Certification: According to International Atomic Energy Agency (IAEA) standards, these sources must undergo rigorous testing—including impact, vibration, puncture, and heat resistance—to achieve "Special Form" certification.
• Containment Purpose: Unlike unsealed sources used in nuclear medicine (radiopharmaceuticals), a sealed source is designed to remain physically intact throughout its entire working life and subsequent disposal.

Core Functionality

Sealed radioactive sources are radioactive materials encapsulated in secure metal housings that allow controlled emission of ionizing radiation while preventing leakage of the radioactive substance. They serve as foundational components in industrial, medical, scientific, and safety applications.

• Common Isotopes: Cobalt-60, iridium-192, cesium-137, and strontium-90 (selected based on energy spectrum, half-life, and application suitability).
• Key Roles: Industrial inspection, cancer treatment, and materials analysis.

Market Segmentation

By Type

• Cobalt-60
• Iridium-192
• Americium-241
• Selenium-75

By IAEA Safety Category

• Cat 1
• Cat 2
• Cat 3
• Cat 4
• Cat 5

By Type of Radiation

• Alpha Source
• Beta Source

By Application

• Medical: Fundamental to radiation therapy and diagnostic procedures. Cobalt-60 is used in external beam radiation therapy, while isotopes like iridium-192 and ruthenium-106 are used in brachytherapy for treating cancers of the cervix, prostate, and other organs. The segment is driven by rising cancer incidence, aging populations, and expanding oncology services.
• Industrial: Critical for non-destructive testing (NDT) and process measurement.
• Gamma Radiography: Iridium-192 and cobalt-60 power industrial gamma cameras for inspecting welds, pipelines, and pressure vessels.
• Gauging: Radiation-based density, thickness, and level gauges used in manufacturing and chemical processing for real-time control.
• Others

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Market Dynamics

Growth Drivers and Trends

• Industrial Demand: Robust demand driven by investments in infrastructure, energy systems, and manufacturing automation, particularly in Asia-Pacific and North America.
• Medical Expansion: The medical radioactive source market is projected to grow steadily over the next decade, specifically in therapeutic and imaging applications.
• Emerging Markets: Growth is expected in Asia-Pacific, Africa, and Latin America due to investments in healthcare and infrastructure.
• Future Innovation Focus: Innovation in lifecycle management, safety integration, green isotopic technologies, secure handling, end-of-use recycling, and responsive regulatory compliance.

Challenges and Competitive Landscape

• Regulatory Frameworks: The market is heavily shaped by IAEA and national regulations governing the entire lifecycle (manufacturing, transportation, security, licensing, leak testing, and disposal). While enhancing safety, these increase compliance costs and entry barriers. Some regions use real-time monitoring and GPS tracking for high-risk sources.
• Technological Alternatives:
• Industrial: Non-radioactive X-ray and laser-based gauges offer alternatives for thickness and density measurements without regulatory constraints.
• Sterilization: Low-temperature vapor and advanced plasma systems are emerging as substitutes for gamma irradiation in certain medical tool applications.
• Competitive Advantage: Sealed sources maintain dominance in applications requiring deep material penetration and stable, long-term radiation output.

Report Methodology and Scope

Produced by LPI (LP Information), the "Sealed Radioactive Source Industry Forecast" provides a comprehensive analysis of the global landscape.

• Scope: Reviews total world sales in 2025 and provides projected sales analysis for 2026 through 2032.
• Analysis Depth: Includes breakdowns by region, market sector, and sub-sector in US$ millions. The report highlights trends in product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Insights: Analyzes leading global companies regarding their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.
• Methodology: Uses a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs.

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolio, and market penetration:

• NRG
• Rosatom
• NTP Radioisotopes
• ANSTO
• Nordion
• IRE
• Curium Pharma
• Eckert & Ziegler Strahlen
• China Isotope & Radiation Corporation (CIRC)
• Polatom

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Sealed Radioactive Source Market Size (2021-2032)

    • 2.1.2 Sealed Radioactive Source Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Sealed Radioactive Source by Country/Region (2021, 2025 & 2032)

  • 2.2 Sealed Radioactive Source Segment by Type

    • 2.2.1 Cobalt-60

    • 2.2.2 Iridium-192

    • 2.2.3 Americium-241

    • 2.2.4 Selenium-75

    • 2.2.5 Sealed Radioactive Source Market Size by Type

      • 2.2.5.1 Sealed Radioactive Source Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Sealed Radioactive Source Market Size Market Share by Type (2021-2026)

  • 2.3 Sealed Radioactive Source Segment By IAEA Safety Category

    • 2.3.1 Cat 1

    • 2.3.2 Cat 2

    • 2.3.3 Cat 3

    • 2.3.4 Cat 4

    • 2.3.5 Cat 5

    • 2.3.6 Sealed Radioactive Source Market Size By IAEA Safety Category

      • 2.3.6.1 Sealed Radioactive Source Market Size CAGR By IAEA Safety Category (2021 VS 2025 VS 2032)
      • 2.3.6.2 Global Sealed Radioactive Source Market Size Market Share By IAEA Safety Category (2021-2026)

  • 2.4 Sealed Radioactive Source Segment By Type of Radiation

    • 2.4.1 Alpha Source

    • 2.4.2 Beta Source

    • 2.4.3 Sealed Radioactive Source Market Size By Type of Radiation

      • 2.4.3.1 Sealed Radioactive Source Market Size CAGR By Type of Radiation (2021 VS 2025 VS 2032)
      • 2.4.3.2 Global Sealed Radioactive Source Market Size Market Share By Type of Radiation (2021-2026)

  • 2.5 Sealed Radioactive Source Segment by Application

    • 2.5.1 Medical

    • 2.5.2 Industrial

    • 2.5.3 Others

    • 2.5.4 Sealed Radioactive Source Market Size by Application

      • 2.5.4.1 Sealed Radioactive Source Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.5.4.2 Global Sealed Radioactive Source Market Size Market Share by Application (2021-2026)

• 3 Sealed Radioactive Source Market Size by Player

  • 3.1 Sealed Radioactive Source Market Size Market Share by Player

    • 3.1.1 Global Sealed Radioactive Source Revenue by Player (2021-2026)

    • 3.1.2 Global Sealed Radioactive Source Revenue Market Share by Player (2021-2026)

  • 3.2 Global Sealed Radioactive Source Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Sealed Radioactive Source by Region

  • 4.1 Sealed Radioactive Source Market Size by Region (2021-2026)

  • 4.2 Global Sealed Radioactive Source Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Sealed Radioactive Source Market Size Growth (2021-2026)

  • 4.4 APAC Sealed Radioactive Source Market Size Growth (2021-2026)

  • 4.5 Europe Sealed Radioactive Source Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Sealed Radioactive Source Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Sealed Radioactive Source Market Size by Country (2021-2026)

  • 5.2 Americas Sealed Radioactive Source Market Size by Type (2021-2026)

  • 5.3 Americas Sealed Radioactive Source Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Sealed Radioactive Source Market Size by Region (2021-2026)

  • 6.2 APAC Sealed Radioactive Source Market Size by Type (2021-2026)

  • 6.3 APAC Sealed Radioactive Source Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Sealed Radioactive Source Market Size by Country (2021-2026)

  • 7.2 Europe Sealed Radioactive Source Market Size by Type (2021-2026)

  • 7.3 Europe Sealed Radioactive Source Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Sealed Radioactive Source by Region (2021-2026)

  • 8.2 Middle East & Africa Sealed Radioactive Source Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Sealed Radioactive Source Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Sealed Radioactive Source Market Forecast

  • 10.1 Global Sealed Radioactive Source Forecast by Region (2027-2032)

    • 10.1.1 Global Sealed Radioactive Source Forecast by Region (2027-2032)

    • 10.1.2 Americas Sealed Radioactive Source Forecast

    • 10.1.3 APAC Sealed Radioactive Source Forecast

    • 10.1.4 Europe Sealed Radioactive Source Forecast

    • 10.1.5 Middle East & Africa Sealed Radioactive Source Forecast

  • 10.2 Americas Sealed Radioactive Source Forecast by Country (2027-2032)

    • 10.2.1 United States Market Sealed Radioactive Source Forecast

    • 10.2.2 Canada Market Sealed Radioactive Source Forecast

    • 10.2.3 Mexico Market Sealed Radioactive Source Forecast

    • 10.2.4 Brazil Market Sealed Radioactive Source Forecast

  • 10.3 APAC Sealed Radioactive Source Forecast by Region (2027-2032)

    • 10.3.1 China Sealed Radioactive Source Market Forecast

    • 10.3.2 Japan Market Sealed Radioactive Source Forecast

    • 10.3.3 Korea Market Sealed Radioactive Source Forecast

    • 10.3.4 Southeast Asia Market Sealed Radioactive Source Forecast

    • 10.3.5 India Market Sealed Radioactive Source Forecast

    • 10.3.6 Australia Market Sealed Radioactive Source Forecast

  • 10.4 Europe Sealed Radioactive Source Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Sealed Radioactive Source Forecast

    • 10.4.2 France Market Sealed Radioactive Source Forecast

    • 10.4.3 UK Market Sealed Radioactive Source Forecast

    • 10.4.4 Italy Market Sealed Radioactive Source Forecast

    • 10.4.5 Russia Market Sealed Radioactive Source Forecast

  • 10.5 Middle East & Africa Sealed Radioactive Source Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Sealed Radioactive Source Forecast

    • 10.5.2 South Africa Market Sealed Radioactive Source Forecast

    • 10.5.3 Israel Market Sealed Radioactive Source Forecast

    • 10.5.4 Turkey Market Sealed Radioactive Source Forecast

  • 10.6 Global Sealed Radioactive Source Forecast by Type (2027-2032)

  • 10.7 Global Sealed Radioactive Source Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Sealed Radioactive Source Forecast

• 11 Key Players Analysis

  • 11.1 NRG

    • 11.1.1 NRG Company Information

    • 11.1.2 NRG Sealed Radioactive Source Product Offered

    • 11.1.3 NRG Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 NRG Main Business Overview

    • 11.1.5 NRG Latest Developments

  • 11.2 Rosatom

    • 11.2.1 Rosatom Company Information

    • 11.2.2 Rosatom Sealed Radioactive Source Product Offered

    • 11.2.3 Rosatom Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Rosatom Main Business Overview

    • 11.2.5 Rosatom Latest Developments

  • 11.3 NTP Radioisotopes

    • 11.3.1 NTP Radioisotopes Company Information

    • 11.3.2 NTP Radioisotopes Sealed Radioactive Source Product Offered

    • 11.3.3 NTP Radioisotopes Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 NTP Radioisotopes Main Business Overview

    • 11.3.5 NTP Radioisotopes Latest Developments

  • 11.4 ANSTO

    • 11.4.1 ANSTO Company Information

    • 11.4.2 ANSTO Sealed Radioactive Source Product Offered

    • 11.4.3 ANSTO Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 ANSTO Main Business Overview

    • 11.4.5 ANSTO Latest Developments

  • 11.5 Nordion

    • 11.5.1 Nordion Company Information

    • 11.5.2 Nordion Sealed Radioactive Source Product Offered

    • 11.5.3 Nordion Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Nordion Main Business Overview

    • 11.5.5 Nordion Latest Developments

  • 11.6 IRE

    • 11.6.1 IRE Company Information

    • 11.6.2 IRE Sealed Radioactive Source Product Offered

    • 11.6.3 IRE Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 IRE Main Business Overview

    • 11.6.5 IRE Latest Developments

  • 11.7 Curium Pharma

    • 11.7.1 Curium Pharma Company Information

    • 11.7.2 Curium Pharma Sealed Radioactive Source Product Offered

    • 11.7.3 Curium Pharma Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Curium Pharma Main Business Overview

    • 11.7.5 Curium Pharma Latest Developments

  • 11.8 Eckert & Ziegler Strahlen

    • 11.8.1 Eckert & Ziegler Strahlen Company Information

    • 11.8.2 Eckert & Ziegler Strahlen Sealed Radioactive Source Product Offered

    • 11.8.3 Eckert & Ziegler Strahlen Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Eckert & Ziegler Strahlen Main Business Overview

    • 11.8.5 Eckert & Ziegler Strahlen Latest Developments

  • 11.9 China Isotope & Radiation Corporation (CIRC)

    • 11.9.1 China Isotope & Radiation Corporation (CIRC) Company Information

    • 11.9.2 China Isotope & Radiation Corporation (CIRC) Sealed Radioactive Source Product Offered

    • 11.9.3 China Isotope & Radiation Corporation (CIRC) Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 China Isotope & Radiation Corporation (CIRC) Main Business Overview

    • 11.9.5 China Isotope & Radiation Corporation (CIRC) Latest Developments

  • 11.10 Polatom

    • 11.10.1 Polatom Company Information

    • 11.10.2 Polatom Sealed Radioactive Source Product Offered

    • 11.10.3 Polatom Sealed Radioactive Source Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Polatom Main Business Overview

    • 11.10.5 Polatom Latest Developments

• 12 Research Findings and Conclusion